VYGR — Voyager Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Annual balance sheet for Voyager Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	133	119	231	267	196
Net Total Accounts Receivable
Net Total Receivables	0.748	0.639	84.5	4.49	2.92
Prepaid Expenses
Total Other Current Assets
Total Current Assets	137	124	320	277	203
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	55.4	33.3	30	47.7	41.6
Long Term Investments
Other Long Term Assets
Total Assets	194	159	351	393	252
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	51	72.6	64.5	49.8	26.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	98.8	100	115	93.3	56.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	95.1	59	236	300	196
Total Liabilities & Shareholders' Equity	194	159	351	393	252
Total Common Shares Outstanding